Amgen

Teva slumps after Express Scripts funds migraine rivals in US
Teva slumps after Express Scripts funds migraine rivals in US
Pharmaforum
PBMs
Teva Pharmaceutical
migraines
Ajovy
Express Scripts
Eli Lilly
Amgen
Flag link:
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Flag link:
Trump wants drug commercials to include prices. These five companies have the most at stake
Trump wants drug commercials to include prices. These five companies have the most at stake
Stat
Donald Trump
drug ads
drug pricing
Pfizer
AbbVie
Eli Lilly
Amgen
Allergan
Flag link:
Amgen, Novartis and Banner Alzheimer's Institute Team on 2 Alzheimer's Prevention Trials
Amgen, Novartis and Banner Alzheimer's Institute Team on 2 Alzheimer's Prevention Trials
BioSpace
Amgen
Novartis
Alzheimer's disease
preventative medicine
Flag link:
7 drugmakers to watch during Q3 earnings
7 drugmakers to watch during Q3 earnings
Biopharma Dive
earnings
Novartis
Gilead Sciences
Amgen
Pfizer
GSK
AbbVie
Regeneron
Flag link:
Here's Why bluebird bio Dropped 13.3% in September
Here's Why bluebird bio Dropped 13.3% in September
Motley Fool
Bluebird Bio
Amgen
Flag link:
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
Pfizer, J&J, Amgen and Roche Start a Bare-Knuckle Brawl Over Biosimilars
BioSpace
Pfizer
Amgen
Roche
FDA
social media
biosimilars
Flag link:
Moody's picks 5 early winners in biosimilar market
Moody's picks 5 early winners in biosimilar market
Biopharma Dive
biosimilars
Pfizer
Biogen
Novartis
Amgen
Mylan Labs
Flag link:
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Flag link:
3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph
3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph
Yahoo/Motley Fool
Amarin
Vascepa
Amgen
Sanofi
Regeneron
Flag link:
Giant Amgen joins a nascent effort to build a new biotech hub in LA
Giant Amgen joins a nascent effort to build a new biotech hub in LA
Endpoints
Amgen
BioLA
Los Angeles
Flag link:
Mylan biosimilar to stress test Amgen Neulasta franchise, analyst predicts
Mylan biosimilar to stress test Amgen Neulasta franchise, analyst predicts
Biopharma Dive
Amgen
Neulasta
biosimilars
Flag link:
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Motley Fool
Bluebird Bio
Amgen
Celgene
AMG-420
bb2121
Flag link:
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Amgen, Sandoz begin biosimilar trial with top-selling Enbrel at stake
Biopharma Dive
Amgen
Sandoz
Enbrel
biosimilars
Novartis
Flag link:
Amgen Offering Golden Ticket for Biotech Startups
Amgen Offering Golden Ticket for Biotech Startups
BioSpace
Amgen
biotech
startups
Flag link:
Can Amgen's new-and-improved Kyprolis kick-start myeloma sales?
Can Amgen's new-and-improved Kyprolis kick-start myeloma sales?
Fierce Pharma
Amgen
Kyprolis
Multiple Myeloma
Flag link:
Gilead steals new commercial chief from Amgen to tackle big sales challenges
Gilead steals new commercial chief from Amgen to tackle big sales challenges
Fierce Pharma
Gilead Sciences
Amgen
Laura Hamill
Flag link:
Pfizer Calls for FDA Guidance to Address False and Misleading Biosimilar Ads
Pfizer Calls for FDA Guidance to Address False and Misleading Biosimilar Ads
RAPS.org
Pfizer
FDA
biosimilars
Amgen
Genentech
drug ads
Flag link:
Aimovig launch bolsters hopes for blockbuster sales
Aimovig launch bolsters hopes for blockbuster sales
Biopharma Dive
Aimovig
Amgen
Novartis
migraines
Flag link:
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Citing appeals court 'anarchy,' Amgen asks SCOTUS to weigh its PCSK9 patent spat with Sanofi
Fierce Pharma
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
Supreme Court
Praluent
Repatha
Flag link:

Pages